Ipamorelin + Tesamorelin Blend dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (1200 mcg @ 75 kg). Educational only, never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 748–1012 mcg | 0.75–1.01 mL | 30–41 units0.30–0.40 mL | – |
| 60–75 kg / 132–165 lb | 918–1242 mcg | 0.92–1.24 mL | 37–50 units0.37–0.50 mL | – |
| 75–90 kg / 165–198 lb | 1122–1518 mcg | 1.12–1.52 mL | 45–61 units0.45–0.61 mL | – |
| 90–105 kg / 198–231 lb | 1326–1794 mcg | 1.33–1.79 mL | 53–72 units0.53–0.72 mL | – |
| >105 kg / >231 lb | 1530–2070 mcg | 1.53–2.07 mL | 61–83 units0.61–0.83 mL | – |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for Ipamorelin + Tesamorelin Blend; the elapsed-time column is hidden.
Ipamorelin + Tesamorelin Blend by goal
Read Ipamorelin + Tesamorelin Blend's profile and dosing through a specific research-goal lens.
Dose & PK references
Selected from the Ipamorelin + Tesamorelin Blend bibliography for relevance to dosing and pharmacokinetics.
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.